The need for continued monitoring of antibiotic resistance patterns in clinical isolates of Staphylococcus aureus from London and Malta

Annals of Clinical Microbiology and Antimicrobials

Volumn 9, Issue , 2010, Pages

  Gould, Simon W J ^a   Cuschieri, Paul ^b   Rollason, Jess ^c   Hilton, Anthony C ^c   Easmon, Sue ^a   Fielder, Mark D ^a  

^a KINGSTON UNIVERSITY   (United Kingdom)

^b ST LUKE S HOSPITAL   (Malta)

^c ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; METICILLIN; PENICILLIN G; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BIOLOGICAL MONITORING; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SURVEILLANCE; GENERAL HOSPITAL; GEOGRAPHIC DISTRIBUTION; INFECTION RATE; MALTA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; UNITED KINGDOM; BACTEREMIA; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, BACTERIAL; HUMANS; LONDON; MALTA; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 77954677168     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-9-20     Document Type: Article

References (31)

1. Brundtland GH. Overcoming antimicrobial resistance world health report on infectious diseases 2000. 2000, Source., http://www.who.int/infectious-disease-report/2000/other_versions/index-rpt2000_text.html
2. Department of Health Getting Ahead of the Curve; A stategy for comating infectious disease (including other aspects of health protection). 2002, Source, Department of Health., http://www.pathologyimprovement.nhs.uk/%5Cdocuments%5Ckey_documents%5CGetting_Ahead_of_the_Curve.pdf
3. Anon 2 Mandatory surveillance of healthcare associated infection report. HPP 2006, 6-25. Anon 2.
4. Anon 3 Surveillance of healthcare associated infections report. 2007, Source, Anon 3., http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1196942166935?p=1158945066450
5. European Antimicrobial Resistance Surveillance System European Antimicrobial Resistance Surveillance System Annual Report 2008. 2008, Source, European Antimicrobial Resistance Surveillance System., http://www.rivm.nl/earss/Images/EARSS%202008_final_tcm61-65020.pdf
6. Andrews JM, . BSAC Working Party on Susceptibility Testing BSAC standardized disc susceptibility testing method (version 6). J Antimicrob Chemother 2007, 60:20-41. 10.1093/jac/dkm110, 17460026, BSAC Working Party on Susceptibility Testing.
7. Hubert SK, Mohammed JM, Fridkin SK, Gaynes RP, McGowan JE, Tenover FC. Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected U.S. Hospitals. J Clin Microbiol 1999, 37:3590-3593. 85700, 10523558.
8. CDC Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR 2002, 51:565-567. CDC.
9. Trakulsomboon S, Danchaivijitr S, Rongrungrang Y, Dhiraputra C, Susaemgrat W, Ito T, Hiramatsu K. First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand. J Clin Micro 2001, 39:591-595.
10. Tsiodras S, Gold HS, Sakoulas G, Eliopoulos GM, Wennerstan C, Vankataraman L, Moellering RC, Ferraro MJ. Linezolid resistance in a clinical isolates of Staphylococcus aureus. The Lancet 2001, 358:207-208.
11. Wilson P, Andrews JA, Charleworth R, Walesby R, Singer M, Ferrell DJ, Robbins M. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chem 1997, 40:135-146.
12. Hill RLR, Kearns AM, Nash J, North SE, Pike R, Newson T, Woodford N, Calver R, Livermore DM. Linezolid-resistant ST36 methicillin-resistant Staphylococcus aureus associated with prolonged linezolid treatment in two paediatric cystic fibrosis patients. J Antimicrob Chemother 2010, 65:442-445. 10.1093/jac/dkp494, 20089543.
13. Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hagement JC. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clinical infectious disease 2008, 46:668-674.
14. Aligholi M, Emaneini M, Jabalameli F, Shahsavan S, Dabiri H, Sedaght H. Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran. Med Princ Pract 2008, 17:432-434. 10.1159/000141513, 18685289.
15. Saha B, Singh AK, Ghosh A, Bal M. Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia). J Med Microbiol 2008, 57:72-79. 10.1099/jmm.0.47144-0, 18065670.
16. Zhu W, Clark NC, McDougal LK, Hageman J, McDonald LC, Patel JB. Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan. Antimicrob Agents Chemother 2008, 52(4):52-457.
17. Reyes J, Hidalgo M, Di{dotless}'az L, Rinco'n S, Moreno J, Vanegas N, Castanñeda E, Arias CA. Characterization of macrolide resistance in Gram-positive cocci from Colombian hospitals:a countrywide surveillance. Int J Infect Dis 2007, 11:329-36. 10.1016/j.ijid.2006.09.005, 17320446.
18. Gould SWJ, Rollason J, Hilton AC, Cuschieri P, McAuliffe L, Easmon SL, Fielder MD. UK epidemic strains of methicillin-resistant Staphylococcus aureus in clinical samples from Malta. J Med Microbio 2008, 57:1394-1398.
19. Leach J, Thoppil R, Fell A. Antibiotic guidelines for adults. Internal Hospital Report 2001, Kingston Hospital, London.
20. Borg MA, Cuschieri P, Azzpardi CM, Zarb P. Antimicrobial prescribing guidelines government health services. Internal Hospital Report 2004, St. Luke's hospital, Malta.
21. Hussain A, Alleyne S, Jenkins D. A survey of attitudes towards methicillin-resistant Staphylococcus aureus bacteraemias amongst United Kingdom microbiologists. J Antimicrob Chemother 2010, 65:347-349. 10.1093/jac/dkp456, 20008906.
22. Conceição T, Tavares A, Miragaia M, hyde K, Aires-de-Sousa M, de Lencastre H. Prevalence and clonality of methicillin-resistant Staphylococcus aureus (MRSA) in the Atlantic Azores islands: predmonanace of SCCmec types IV, V and VI. Eur J clin Microbiol Infect Dis 2010, 29:543-550. 10.1007/s10096-010-0892-4, 2854357, 20229224.
23. Gales AC, Sader HS, Ribeiro J, Zoccoli C, Barth A, Pignatari AC. Antimicroibal susceptibility of gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY program (2005-2008). Braz J Infect Dis 2009, 13:90-98.
24. Ortega-Loayza AG, Diamantis SA, Gilligan P, Morrel DS. Characterisation of Staphylococcus aureus cutaneous infections in a paediatric dermatology tertiary health care outpatient facility. J Am Acad Dermatol 2010, 62:804-811. 10.1016/j.jaad.2009.07.030, 20176410.
25. Jarvs WR. Preventing the meregence of multidrug-resistant microorganism through antimicrobial use controls: the complexity of the problem. Inect Control Hosp Epidemiol 1996, 17:490-495.
26. Duncan RA. Controlling use of antimicrobial agents. Control Hosp Epidemiol 1997, 18:260-266.
27. Burke JP. Antibiotic resistance--squeezing the balloon?. JAMA 1998, 280:1270-1271. 10.1001/jama.280.14.1270, 9786379.
28. Cooke FJ, Holmes AH. The missing care bundle: antibiotic prescribing in hospitals. Int J Antimicrob Agents 2007, 30:25-9. 10.1016/j.ijantimicag.2007.03.003, 17499482.
29. Nathwani D. Antimicrobial prescribing policy and practice in Scotland: recommendations for good antimicrobial practice in acute hospitals. J Antimicrob Chemother 2006, 57:1189-1196. 10.1093/jac/dkl137, 16624876.
30. Drew RH. Antimicrobial stewardship programs: haws to start and steer a successful program. J Manag Care Pharm 2009, 15:S18-S23.
31. Scheetz MH, Bolon MK, Postelnick M, Noskin GA, Lee TA. Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis. J Antimicrob Chemother 2009, 63:816-825. 10.1093/jac/dkp004, 19202150.